Daily FNArena News - Australia

With the transformation plan moving at a glacial pace brokers have pushed Metcash’s recovery further into the future.

The Commonwealth Department of Social Security has reversed a favourable tax treatment for Challenger Financial’s aged care annuities Brokers review the implications.

Weekly update on recommendation, target price, and earnings forecast changes.

Baillieu Holst is enthusiastic about Mesoblast’s plans to launch stem cell therapy for GvHD in 2016 and believes upside potential for the stock is substantial.

FNArena’s weekly update on short positions in the Australian share market.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Paladin Energy has made an equity placement to a Chinese equity firm, resolving the company’s near term debt issue and allowing for exploitation of higher uranium prices.

The gold price has fallen steadily in 2014 and is facing many headwinds, but all is not lost for Australian gold producers. Brokers outline their preferences.

Regardless of the likely recommendations of the Financial Services Inquiry, brokers consider Australia’s banks are well placed for future returns.

BHP Billiton has reduced its capex and increased its cost cutting targets further, while investor concerns now centre on dividend policy.